170 related articles for article (PubMed ID: 6335750)
21. Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers.
Chakvetadze C; Roussin C; Roux J; Mallet V; Petinelli ME; Pol S
Vaccine; 2011 Apr; 29(16):2846-9. PubMed ID: 21338675
[TBL] [Abstract][Full Text] [Related]
22. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
[TBL] [Abstract][Full Text] [Related]
23. [Current views on the subject of vertical transmission and prevention of hepatitis B].
Turrisi A; Buccellato A; Gucciardo D; Mignano-Marù R; Ziino O; Borsellino F; Lantieri P; Lazzara A
Minerva Pediatr; 1989 Oct; 41(10):505-14. PubMed ID: 2693928
[TBL] [Abstract][Full Text] [Related]
24. [Results of a prospective study for the prevention of viral hepatitis in neonates with HBsAg positive mothers].
Péci J; Danys J; Bauer F
Cesk Pediatr; 1989 Mar; 44(3):172-3. PubMed ID: 2731288
[No Abstract] [Full Text] [Related]
25. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy.
Mele A; Tancredi F; Romanò L; Giuseppone A; Colucci M; Sangiuolo A; Lecce R; Adamo B; Tosti ME; Taliani G; Zanetti AR
J Infect Dis; 2001 Oct; 184(7):905-8. PubMed ID: 11509998
[TBL] [Abstract][Full Text] [Related]
26. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
[TBL] [Abstract][Full Text] [Related]
27. [Adjustment of the hepatitis-B vaccination scheme for newborns born to hepatitis-B virus carriers as of 1 January 2006].
Geelen SP
Ned Tijdschr Geneeskd; 2006 Feb; 150(8):415-8. PubMed ID: 16538839
[TBL] [Abstract][Full Text] [Related]
28. [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies].
Manzillo G; Sagnelli E; Da Villa G; Maio G; Izzo CM; Felaco F; Filippini P; Buonocore S; Piccinino F
Minerva Med; 1980 Oct; 71(42):3067-71. PubMed ID: 7266910
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of combined active-passive immunization in neonates born to hepatitis B surface antigen positive mothers: a study of 60 cases].
Selton D; André M; Gosselin J; Hascoët JM
J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):500-9. PubMed ID: 19656641
[TBL] [Abstract][Full Text] [Related]
30. Selectivity in IgG subclass response to hepatitis B vaccine in infants born to HBsAg-positive mothers.
Rossi ME; Azzari C; Resti M; Appendino C; Pezzati P; Vierucci A
Clin Exp Immunol; 1988 May; 72(2):196-200. PubMed ID: 3409544
[TBL] [Abstract][Full Text] [Related]
31. A program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women.
Klontz KC
West J Med; 1987 Feb; 146(2):195-9. PubMed ID: 3825119
[TBL] [Abstract][Full Text] [Related]
32. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
33. Necessity for routine obstetric screening for hepatitis B surface antigen.
Greenspoon JS; Martin J; Greenspoon RL; McNamara BT
J Reprod Med; 1989 Sep; 34(9):655-8. PubMed ID: 2530344
[TBL] [Abstract][Full Text] [Related]
34. Prevention of chronic HBsAg carriership in infants of HBsAg-positive mothers by hepatitis B immunoglobulin.
Reesink HW; Reesink-Brongers EE; Lafeber-Schut BJ; Kalshoven-Benschop J; Brummelhuis HG
Acta Haematol Pol; 1980; 11(2):79-81. PubMed ID: 7424485
[No Abstract] [Full Text] [Related]
35. Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran.
Soleimani Amiri MJ; Hasanjani Roushan MR; Baiany M; Taheri H; Hasanjani Roushan M
J Clin Virol; 2010 Dec; 49(4):283-5. PubMed ID: 20846904
[TBL] [Abstract][Full Text] [Related]
36. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
37. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis.
Hsu HY; Chang MH; Ni YH; Lin HH; Wang SM; Chen DS
Hepatology; 1997 Sep; 26(3):786-91. PubMed ID: 9303514
[TBL] [Abstract][Full Text] [Related]
38. [Active and passive immunization against hepatitis B virus infection].
Colak H
Mikrobiyol Bul; 1982 Jan; 16(1):71-6. PubMed ID: 7144619
[TBL] [Abstract][Full Text] [Related]
39. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunization of infants at risk.
Gilbert GL
Med J Aust; 1984 Aug; 141(4):213-6. PubMed ID: 6482756
[TBL] [Abstract][Full Text] [Related]
40. [Immunoprophylaxis of hepatitis B. 4. Identification of risk groups, recommendations for inoculation, new developments].
Zoulek G; Jilg W; Deinhardt F
Dtsch Med Wochenschr; 1983 Aug; 108(34):1263-8. PubMed ID: 6224668
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
